Literature DB >> 23004678

Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers.

Hong Shen1, Jinlin Huang, Haiping Pei, Shan Zeng, Yiming Tao, Liangfang Shen, Liang Zeng, Hong Zhu.   

Abstract

The aim of the present study is to profile differentially expressed protein markers between left-sided colon cancer (LSCC) and right-sided colon cancer (RSCC). Fresh tumor tissue samples from LSCC (n = 7) and RSCC (n = 7) groups were analyzed by two-dimensional electrophoresis coupled with MALDI-TOF-MS, followed by Western blotting. In 50 paraffin embedded samples from each group, levels of four differentially expressed proteins (identified by proteomics analysis) were measured by tissue microarray with immunohistochemistry staining to compare the different protein markers between LSCC and RSCC. Sixteen proteins were found to be differentially expressed between LSCC and RSCC. Ten proteins including HSP-60 and PDIA1 were identified to be highly expressed in LSCC (P < 0.01 or P < 0.05), while the expression of six proteins including EEF1D and HSP-27 were higher in RSCC (P < 0.01 or P < 0.05). Virtually all of the indentified proteins were involved in cellular energy metabolism, protein folding/unfolding, and/or oxidative stress. Human colon tumors at various locations have different proteomic biomarkers. Differentially expressed proteins associated with energy metabolism, protein folding/unfolding and oxidative stress contribute to different tumorigenesis, tumor progression, and prognosis between left- and right-sided colon cancer.
© 2012 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23004678     DOI: 10.1111/cas.12029

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  13 in total

1.  Comparative proteomic analysis of fibrosarcoma and skin fibroblast cell lines.

Authors:  Ogunc Meral; Hamdi Uysal
Journal:  Tumour Biol       Date:  2014-10-01

2.  A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites.

Authors:  Yan Zhang; Junli Ma; Sai Zhang; Ganlu Deng; Xiaoling Wu; Jingxuan He; Haiping Pei; Hong Shen; Shan Zeng
Journal:  Int J Colorectal Dis       Date:  2015-06-09       Impact factor: 2.571

3.  Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study.

Authors:  Kunpeng Liu; Yuan Ren; Lijuan Pang; Yan Qi; Wei Jia; Lin Tao; Zhengyan Hu; Jin Zhao; Haijun Zhang; Li Li; Haifeng Yue; Juan Han; Weihua Liang; Jianming Hu; Hong Zou; Xianglin Yuan; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 4.  Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach.

Authors:  Mona Zamanian-Azodi; Mostafa Rezaei-Tavirani; Hadi Hasanzadeh; Sara Rahmati Rad; Sona Dalilan
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

5.  P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.

Authors:  Hecun Zou; Chunjie Wen; Zhigang Peng; Ying-Υing Shao; Lei Hu; Shuang Li; Cuilin Li; Hong-Hao Zhou
Journal:  Oncol Rep       Date:  2017-12-04       Impact factor: 3.906

6.  EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling.

Authors:  Dong-Dong Cheng; Shi-Jie Li; Bin Zhu; Shu-Min Zhou; Qing-Cheng Yang
Journal:  J Exp Clin Cancer Res       Date:  2018-03-06

7.  N-glycomic profiling of colorectal cancer according to tumor stage and location.

Authors:  Matilda Holm; Pirjo Nummela; Annamari Heiskanen; Tero Satomaa; Tuomas Kaprio; Harri Mustonen; Ari Ristimäki; Caj Haglund
Journal:  PLoS One       Date:  2020-06-29       Impact factor: 3.240

8.  Plasma protein expression differs between colorectal cancer patients depending on primary tumor location.

Authors:  Matilda Holm; Sakari Joenväärä; Mayank Saraswat; Tiialotta Tohmola; Ari Ristimäki; Risto Renkonen; Caj Haglund
Journal:  Cancer Med       Date:  2020-05-26       Impact factor: 4.452

9.  The Immunome of Colon Cancer: Functional In Silico Analysis of Antigenic Proteins Deduced from IgG Microarray Profiling.

Authors:  Johana A Luna Coronell; Khulan Sergelen; Philipp Hofer; István Gyurján; Stefanie Brezina; Peter Hettegger; Gernot Leeb; Karl Mach; Andrea Gsur; Andreas Weinhäusel
Journal:  Genomics Proteomics Bioinformatics       Date:  2018-03-02       Impact factor: 7.691

10.  Role of TXNDC5 in tumorigenesis of colorectal cancer cells: In vivo and in vitro evidence.

Authors:  Fengbo Tan; Hong Zhu; Xiao He; Nanhui Yu; Xingwen Zhang; Haifan Xu; Haiping Pei
Journal:  Int J Mol Med       Date:  2018-05-09       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.